Pharmasgp Holding Se (PSGG)

Xetra
21.80
0.00(0.00%)
  • Volume:
    31
  • Bid/Ask:
    21.50/22.00
  • Day's Range:
    21.50 - 22.00
  • Type:Equity
  • Market:Germany
  • ISIN:DE000A2P4LJ5
  • WKN:A2P4LJ

PSGG Overview

Prev. Close
21.8
Day's Range
21.5-22
Revenue
58.86M
Open
22
52 wk Range
14.4-31.5
EPS
0.71
Volume
31
Market Cap
261.6M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
2,340
P/E Ratio
30.59
Beta
-
1-Year Change
-31.45%
Shares Outstanding
12,000,000
Next Earnings Date
Dec 01, 2021
What is your sentiment on Pharmasgp Holding Se?
or
Market is currently closed. Voting is open during market hours.

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellSellStrong SellStrong SellSell
Technical IndicatorsStrong SellStrong SellStrong BuyStrong SellSell
SummaryStrong SellStrong SellStrong SellStrong SellSell

Pharmasgp Holding Se Company Profile

Pharmasgp Holding Se Company Profile

Employees
60
Market
Germany

PharmaSGP Holding SE manufactures non-chemical, over-the-counter drugs, and other healthcare products. The company’s pharmaceutical products include RubaXX pharmaceutical drops for the treatment of rheumatic pain in bones, tendons, and muscles; Restaxil pharmaceutical drops for the treatment of nerve pain in neck and back; Fulminan, a beauty drink for problems in areas such as eye area, buttocks, or thighs; DESEO pharmaceutical drops for sexual weakness; Neradin, a drug for sexual dysfunction; and TAUMEA, a drug for the treatment of vertigo. It also offers products for the treatment of chronic indications, including pain and other age-related ailments. The company sells its products through pharmacies and wholesalers. It exports its products to European countries comprising Austria, Italy, Belgium, and Spain. PharmaSGP Holding SE was founded in 2012 and is based in Gräfelfing, Germany.

Read More
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.